News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Conference News TCT 2015 Companies With Innovative Technologies Compete in TCT Shark Tank October 13, 2015
News Conference News TCT 2015 Asian TAVR Registry Shows Good Procedural and Clinical Results October 11, 2015
News Daily News RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline September 22, 2015
News Daily News Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs Todd Neale September 17, 2015
News Daily News Short-term Readmission Rates Similar After TAVR vs SAVR Todd Neale September 10, 2015
News Daily News A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR Yael L. Maxwell August 30, 2015
News Industry News Colibri Heart Valve Strengthens Patent Portfolio with Receipt of 12th Transcatheter Heart Valve (THV) Patent August 24, 2015
News Industry News Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions August 24, 2015
News Daily News Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR August 20, 2015
News Daily News Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates Yael L. Maxwell August 05, 2015
News Daily News El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos Yael L. Maxwell August 05, 2015
News Industry News Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM July 27, 2015
News Industry News NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults July 13, 2015
News Daily News Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene L.A. McKeown July 13, 2015
News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015
News Industry News SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial June 29, 2015